Search

Enhancing preclinical Covid-19 safety and efficacy studies with the emkaPACK

The COVID-19 pandemic has emphasized the critical need for rapid development and validation of effective treatments and vaccines. Advanced monitoring technologies, such as emkaPACK, play a crucial role in preclinical safety pharmacology and toxicology studies, ensuring the safety and efficacy of new therapeutics.

This application note reviews the significant contributions of emkaPACK in the research and development of Olgotrelvir, the ZF2001 vaccine, and nebulized SARS-CoV-2 neutralizing antibodies.

Download the summary

By browsing this website, you accept the use of cookies for statistical purposes.

Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are set through our site by our advertising partners.

Google Adwords
We use Adwords to track our Conversions through Google Clicks.

Hubspot
We use Hubspot to monitor our traffic and to help us AB test new features.

Google Tag Manager

Save